?

Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Found 16357 publications
Investigation Report on China Salmon Calcitonin Market, 2010-2019 US$ 2,000.00

... Novartis’s salmon calcitonin entered China under the trade name of Miacalcic and later salmon calcitonin made by Lisapharma ...

Jun, 2015 35 pages
Investigation Report on China Rosuvastatin Market, 2010-2019 US$ 2,000.00

... rosuvastatin (rosuvastatin calcium ... rosuvastatin in the Chinese market mainly come from the following companies: IPR Pharmaceuticals (US), Lunan Better Pharmaceutical Co., Ltd, Nanjing Chia Tai Tianqing, Simcere and Zhejiang Jingxin Pharmaceutical Co., Ltd, among which IPR Pharmaceuticals ...

Jun, 2015 35 pages
Investigation Report on China Progesterone Market, 2010-2019 US$ 2,000.00

... progesterone in the Chinese market is imported and made by Fleet (UK) and Capsugel(FR). The rest mainly comes from such local manufacturers as Asen, Zhejiang Xianju Pharmaceutical Co., Ltd ... steroid drugs will keep growing and that with the development of downstream products, the demand for progesterone ...

Jun, 2015 35 pages
Investigation Report on China Ossotide Market, 2010-2019 US$ 2,000.00

... of rheumatoid arthritis (RA) is 0.2%-0.36% and the number of cases is 5-10 million in China. Apart from RA, osteoarthritis, an expression of ... ossotide in China competitive landscape of ossotide in Chinese market price of ossotide made by different enterprises in China market outlook of ossotide in China ...

Jun, 2015 35 pages
Investigation Report on China Moxifloxacin Market, 2010-2019 US$ 2,000.00

... China are mainly produced by Nanjing Youke Pharmaceutical CO., Ltd and The Bayer Group whichowns the larger market share of over 95% for sales value in 2014. As an outstanding antibacterial drug, moxifloxacin ...

Jun, 2015 20 pages
Investigation Report on China Menotropins Market, 2010-2019 US$ 2,000.00

... Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc, Ferring Pharmaceytical Co., Ltd (Germany), Ma’anshan Fengyuan Pharmaceutical Co., Ltd, Yantai North Pharmaceutical Co., Ltd and Shanghai Livzon Pharmaceutical Co., Ltd, among which Shanghai Livzon Pharmaceutical Co., Ltd ...

Jun, 2015 30 pages
Investigation Report on China Levothyroxine Market, 2010-2019 US$ 2,000.00

... Thyroid hormones (TH) have the greatest effect of promoting growth on five-month-old babies or younger ones. Without thyroid hormones ... Levothyroxine enjoys a vast demand in China. Merck (Germany), Berlin-Chemie AG (Germany) and China Associated Pharmaceutical all take up certain market share, among which Merck ...

Jun, 2015 20 pages
Investigation Report on China Glucosamine Market, 2010-2019 US$ 2,000.00

... Glucosamine is of great demand in China. Most of the market share has been occupied by Shanxi Zhongyuanwei Pharmaceutical Co., Ltd, Bright Future Pharmaceutical Laboratories Limited, Rottapharm Ltd, Zhejiang Hisun Pharmaceutical Co., Ltd ...

Jun, 2015 35 pages
Investigation Report on China Ganglioside Market, 2010-2019 US$ 2,000.00

... ganglioside sodium in China, among which Qilu Pharmaceutical Co., Ltd, Medical University Pharmaceutical Co., Ltd, Beijing Science Sun Pharmaceutical Co., Ltd, Changchun Xiangtong Pharmaceutical Co., Ltd and Wellso Pharmaceutical take the lion’s share. The marketing of domestic ganglioside ...

Jun, 2015 35 pages
Investigation Report on China Flurbiprofen Market, 2010-2019 US$ 2,000.00

... Beijing Tide Pharmaceutical Co., Ltd and MIKASA SEIYAKU CO.,LTD, the former having the larger market share of 99% for sales value in 2014. The market size of flurbiprofen in China ...

Jun, 2015 20 pages
Investigation Report on China Etanercept Market, 2010-2019 US$ 2,000.00

... etanercept in the Chinese market is monopolized by Boehringer Ingelheim (Germany). According to CRI’s market survey, the price range of 25 mg (one injection per package) etanercept ...

Jun, 2015 20 pages
Investigation Report on China Entecavir Market, 2010-2019 US$ 2,000.00

... hepatitis B virus (HBV) exceeds 100 million in China, among which 20-30 million suffering from chronic Hepatitis B. ... entecavir in China rose from CNY 30 million in 2006 to CNY 1.207 billion in 2014 and CAGR during this period reached up to 55%. Entecavir made by Sino-American Shanghai Squibb Pharmaceuticals Ltd ...

Jun, 2015 30 pages
Investigation Report on China Cefathiamidine Market, 2010-2019 US$ 2,000.00

... Guangzhou Baiyunshan Pharmaceutical General Factory, cefathiamidine has been written into the Chinese Pharmacopoeia (2005). Ever since its marketing in 2000, the sales value of cefathiamidine ...

Jun, 2015 35 pages
Investigation Report on China Bromhexine Market, 2010-2019 US$ 2,000.00

... bromhexine in the Chinese market mainly comes from local enterprises like Jiangxi Kelun Pharmaceutical Co., Ltd, Jincheng Haisi Pharmaceutical Co., Ltd and Shanxi Powerdone Pharmaceutical Co., Ltd, Shijiazhuang No.4 Pharmaceutical Co., Ltd ...

Jun, 2015 30 pages
Cytokinetics, Inc. - Product Pipeline Review - 2015 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Cytokinetics, Inc.’s pipeline products Reasons to buy Evaluate Cytokinetics, Inc ...

May, 2015 50 pages
Burkholderia Pseudomallei Infections - Pipeline Review, H1 2015 US$ 2,000.00

... Burkholderia Pseudomallei Infections - Pipeline Review, H1 2015’, provides an overview of the Burkholderia Pseudomallei Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Burkholderia Pseudomallei Infections ...

May, 2015 42 pages
Amunix Operating Inc. - Product Pipeline Review - 2015 US$ 1,500.00

... portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Amunix Operating Inc.’s pipeline ...

May, 2015 37 pages
Syphilis Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... Syphilis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Syphilis . It includes an overview of the trial numbers and their recruitment ...

May, 2015 75 pages
Abscess Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials Facilitates clinical trial ...

May, 2015 149 pages
Infectious Diarrhea Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... Infectitious Diarrhea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Infectitious Diarrhea . It includes an overview of the trial numbers and their recruitment ...

Apr, 2015 68 pages
Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015 US$ 2,500.00

Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015' provides data on the Ileus (Intestinal Obstruction) clinical trial ...

Apr, 2015 80 pages
Gastric Ulcers Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... Gastric Ulcers clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastric Ulcers. It includes an overview of the trial numbers and their recruitment ...

Apr, 2015 91 pages
Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... clinical trial report, “Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H1, 2015' provides data on the Functional (Non Ulcer) Dyspepsia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Functional (Non Ulcer) Dyspepsia ...

Apr, 2015 75 pages
Esophageal Diseases Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... Esophageal Diseases clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Esophageal Diseases. It includes an overview of the trial numbers and their recruitment ...

Apr, 2015 103 pages
Emesis (Vomiting) Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... Emesis (Vomiting) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Emesis (Vomiting). It includes an overview of the trial numbers and their recruitment ...

Apr, 2015 97 pages
Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H1, 2015 US$ 2,500.00

Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H1, 2015' provides data on the Corrosive Esophagitis (Erosive Esophagitis) clinical trial ...

Apr, 2015 86 pages
Autoimmune Hepatitis Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... Autoimmune Hepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Autoimmune Hepatitis. It includes an overview of the trial numbers and their recruitment ...

Apr, 2015 61 pages
Chronic Liver Disease Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... clinical trial report, “Chronic Liver Disease Global Clinical Trials Review, H1, 2015' provides an overview of Chronic Liver Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Liver Disease. Report includes an overview of trial ...

May, 2015 73 pages
Future Horizons and Growth Strategies in the Global Therapeutic Drug Monitoring (TDM) Market 2015: Supplier Shares and Country Forecasts US$ 8,500.00

... , such as specimen preparation devices, controls, calibrators and others. Future Horizons and Growth Strategies in the Global Therapeutic Drug Monitoring (TDM) Market 2015 ...

Jun, 2015 313 pages
Future Horizons and Growth Strategies in the European Therapeutic Drug Monitoring (TDM) Market 2015: Supplier Shares and Country Forecasts US$ 6,500.00

... as specimen preparation devices, controls, calibrators and others. Future Horizons and Growth Strategies in the European Therapeutic Drug Monitoring (TDM) Market 2015: Supplier ...

Jun, 2015 291 pages
Future Horizons and Growth Strategies in the Global Drugs of Abuse Testing Market 2015: Supplier Shares and Country Forecasts US$ 8,500.00

... , such as specimen preparation devices, controls, calibrators and others. Future Horizons and Growth Strategies in the Global Drugs of Abuse Testing Market 2015” is a unique ...

Jun, 2015 318 pages
Future Horizons and Growth Strategies in the European Drugs of Abuse Testing Market 2015: Supplier Shares and Country Forecasts US$ 6,500.00

... , such as specimen preparation devices, controls, calibrators and others. Future Horizons and Growth Strategies in the European Drugs of Abuse Testing Market 2015” is a unique ...

Jun, 2015 300 pages
Europe Prebiotics (Nutraceuticals) Market by Application (Functional Food, Functional Beverages, Dietary Supplements, Animal Feed, & Personal Care) by Country (Germany, France, Russia,... US$ 2,650.00

... popular among the consumers in turn benefitting the prebiotics (nutraceuticals) ingredients industry. In this report, the Europe prebiotics (nutraceuticals) market has been broadly discussed by its application ... engaged in market strategies such as mergers & acquisitions, joint venture, new product development and expansion to increase the market share in the Europe prebiotics (nutraceuticals) market. Reasons to Buy ...

Jun, 2015 83 pages
Out-patient Pharmacy Automation Market in the US 2015-2019 US$ 2,500.00

... out-patient pharmacy automation devices market in the US for the period 2015-2019. Based on application, the market can be segmented into the following: automated medication dispensing systems, automated storage and retrieval systems, automated packaging and labeling systems, table-top tablet counters, and automated compounding devices. Technavio's report, Out-patient Pharmacy Automation Devices Market ...

Jun, 2015 68 pages
Global Colorectal Cancer Drugs Market 2015-2019 US$ 3,000.00

... four broad stages. Colorectal cancer can be treated using surgical, chemotherapeutic, biologic, and radiation therapies. Technavio's analysts forecast the global colorectal cancer drugs market to grow at a CAGR ... market at large, as well as the key trends that are emerging in the market. Technavio's report, Global Colorectal Cancer Drugs Market 2015-2019, has been prepared based on an in-depth market ...

Jun, 2015 125 pages
Global Cancer Vaccines Market 2015-2019 US$ 2,500.00

... global cancer vaccines market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various therapeutic and prophylactic cancer vaccines ... the market at large, as well as the key trends that are emerging in the market. Technavio's report, Global Cancer Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis ...

Jun, 2015 64 pages
Global Pharmaceutical Contract Manufacturing Market – By Regions and Vendors - Market Trends and Forecasts (2014 - 2020) US$ 3,850.00

... of the drug from the Pharmaceutical company and then prepare/manufacture in their location. Supply – Demand Scenario: The global Pharmaceutical Contract Manufacturing market was worth $58 billion in 2014 and is projected to reach $84 billion in 2020, at a compound annual growth rate of 6.4%. Active Pharmaceutical Ingredient (API ...

Jun, 2015 125 pages
Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Pipeline Review, H1 2015 US$ 2,000.00

... Invaginata, Bamboo Hair) - Pipeline Review, H1 2015’, provides an overview of the Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair ...

May, 2015 35 pages
Immunservice GmbH - Product Pipeline Review - 2015 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Immunservice GmbH’s pipeline products Reasons to buy Evaluate Immunservice GmbH ...

May, 2015 21 pages
Guillain-Barre Syndrome - Pipeline Review, H1 2015 US$ 2,000.00

Guillain-Barre Syndrome - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Guillain-Barre Syndrome - Pipeline Review, H1 2015’, provides an overview of the Guillain-Barre Syndrome’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Guillain-Barre ...

May, 2015 44 pages
DNAVEC Corporation - Product Pipeline Review - 2015 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the DNAVEC Corporation’s pipeline products Reasons to buy Evaluate DNAVEC Corporation ...

May, 2015 25 pages
Cryptosporidiosis - Pipeline Review, H1 2015 US$ 2,000.00

... Cryptosporidiosis - Pipeline Review, H1 2015’, provides an overview of the Cryptosporidiosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cryptosporidiosis, complete with comparative analysis at various stages, therapeutics assessment ...

May, 2015 34 pages
Investigation Report on China Recombinant Factor Ⅷ Market, 2010-2019 US$ 2,000.00

... and treatment of hemophilia have a huge market. Apart from Bayer Schering, Baxter and Wyeth also make recombinant factor Ⅷ too. After entering China, recombinant factor Ⅷ develops ... report: sales status of recombinant factor Ⅷ in China price of recombinant factor Ⅷ in Chinese market major manufacturers of recombinant factor Ⅷ in Chinese market share of dosage forms of recombinant factor Ⅷ in China market outlook of recombinant factor Ⅷ in China The author suggests ...

Jun, 2015 30 pages
Investigation Report on China Octreotide Market, 2010-2019 US$ 2,000.00

... octreotide in China market share of manufacturers of octreotide in China price of octreotide in Chinese market major manufacturers of octreotide in Chinese market market outlook of octreotide in China ...

Jun, 2015 30 pages
Investigation Report on China Methylprednisolone Market, 2010-2019 US$ 2,000.00

... varieties of steroid’s APIs, half are made in China. As a variety performing well in hospitals in recent years, methylprednisolone, ... methylprednisolone entered China in the late 1990s under the trade names of Medrol (Pfizer) and Solu-Medrol (Pharmacia & Upjohn). The APIs and preparations of methylprednisolone ...

Jun, 2015 30 pages
Investigation Report on China Liraglutide Market, 2011-2019 US$ 2,000.00

... diabetes incidence in China. Liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, was developed by Novo Nordisk in 2008 to treat diabetes. Liraglutide, a derivative attained by attaching a fatty acid molecule to GLP-1 molecule, can reduce the HbA1c level and weight of type 2 diabetes ...

Jun, 2015 25 pages
Investigation Report on China Ezetimibe Market, 2010-2019 US$ 2,000.00

... estimate of the incidence of hyperlipemia is 7%-8% while the actual incidence might be above 10%. Over 100 million people in China have to receive ... this report: market size of ezetimibe in China price of ezetimibe in Chinese market market outlook of ezetimibe in China The author suggests the following groups ...

Jun, 2015 20 pages
Investigation Report on China Edaravone Market, 2010-2019 US$ 2,000.00

... Cerebrovascular disease is one of the three principal diseases that can cause people to death. Acute cerebral infarction which occupies 70% of cerebrovascular disease ...

Jun, 2015 30 pages
Investigation Report on China Doxofylline Market, 2010-2019 US$ 2,000.00

... doxofylline in China market share of manufacturers of doxofylline in China price of doxofylline in Chinese market major manufacturers of doxofylline in Chinese market market outlook of doxofylline in China ...

Jun, 2015 30 pages
Investigation Report on China Desloratadine Market, 2010-2019 US$ 2,000.00

... desloratadine in China market share of manufacturers of desloratadine in China price of desloratadine in Chinese market major manufacturers of desloratadine in Chinese market market outlook of desloratadine in China ...

Jun, 2015 30 pages
1 2 3 4 5 >
Skip to top